Tofacitinib Therapy for the Treatment of Alopecia Areata: Report of 11 Patients

    August 2019 in “ Journal of the American Academy of Dermatology ”
    From the encyclopedia
    Tofacitinib →

    a JAK inhibitor for alopecia areata and other autoimmune conditions

    Alopecia Areata →

    autoimmune disorder causing patchy hair loss

    Studysummary Tofacitinib may help hair regrowth in alopecia areata, but more research is needed. Our plain-language summary of this paper — not a Tressless recommendation.
    The document reported on the use of Tofacitinib therapy for treating alopecia areata in a study involving 11 patients. The study aimed to evaluate the effectiveness of Tofacitinib, a Janus kinase inhibitor, in promoting hair regrowth in individuals with this autoimmune condition. The results indicated that Tofacitinib showed promise as a treatment option, with several patients experiencing significant hair regrowth. However, the small sample size of 11 patients suggested that further research with a larger cohort was necessary to confirm these findings and better understand the long-term efficacy and safety of Tofacitinib for alopecia areata.
    Discuss this study in the Community →